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Our  study  addresses  the  ﬁrst two  weeks  of  the weaning  period  of  piglets  during  which  stressful  phys-
iological  and  environmental  conditions  experienced  by  the  animals  can  promote  the  proliferation  of
pathogens  in  the  digestive  tract.  The  aim  of  the  study  was  to  identify  new  feeding  strategies  that  result  in
boosting  the  gastrointestinal  tract (GIT)  microbiota  of  piglets  and  improve  growth  performance,  reduc-
ing the negative  impact  of  weaning.  In  order  to identify  a new  synbiotic  combination,  12 new  putative
probiotic  strains  of  Biﬁdobacterium  spp.  and  three  non-digestible  oligosaccharides  [NDO]  were  screened
in newly  weaned  piglets.  The  ability  to increase  the  level  of  autochthonous  biﬁdobacteria  and  improve
growth  performance  were  assessed.  Biﬁdobacteria  strains  with  a similar  ability  to  develop  in the  hindgut
showed a  different  effect  on piglet  performance  depending  on the  dose  in  which  they  were  provided.  Our
data  support  the  idea  that the  presence  of fructo-oligosaccharides  would  stimulate  the  occurrence  of  biﬁ-
dobacteria  in  the  caecum.  It was  shown  that  dietary  intake  of  nitrate  can  generate  salivary  nitrite,  which
in turn  is acidiﬁed  in  the  stomach  and  could  have  antimicrobial  activity  against  swallowed  pathogens.  The
efﬁcacy of the  resulting  synbiotic  formula  was  improved  by  adding  nitrate  as  antimicrobial.  To enhance
probiotic  survival  during  gastric  transit,  a  novel  technology  of microencapsulation  was  developed  and
applied to  bacteria.  The  ﬁnal  synbiotic,  containing  the  strain  RA  18 of Biﬁdobacterium  animalis  subsp.
11 ®lactis  [10 cfu/day],  the  prebiotic  Actilight [4%  of  the diet],  and  nitrate  [150  mg KNO3/kg  feed/day]  was
tested  in organic  weaned  piglets  reared  under  ﬁeld  conditions.  Results  show  that the  strain  Ra  18 had
a probiotic  effect  in  organic  weaned  piglets,  as  it colonized  and remained  detectable  in  faecal  samples
until  two  weeks  after  addition.  The  use  of  our  synbiotic  formula  improved  weight  gain, feed  efﬁciency
and  health  status  of  the  weaned  piglets.
© 2011 Royal Netherlands Society for Agricultural Sciences. Published by Elsevier B.V.. Introduction
In conventional farrowing systems, the weaning process is con-
idered as a crucial period in the life of the pigs. This means that
iglets are simultaneously exposed to a large number of stressors,
uch as a separation from the sow, an early and critical transition
rom milk to a diet based on plant polysaccharides, and the end of
he lactational immunity. Furthermore, the sudden interruption of
he maternal milk supply leads to the progressive withdrawal of
he maternal protective IgA that acts locally in the suckling piglet’s
ntestine [1].  These factors combined can disturb the immune func-
ion and the intestinal microbiota equilibrium of the piglets [2–4].
∗ Corresponding author. Tel.: +39 051 2096272; fax: +39 051 2096274.
E-mail address: bruno.biavati@unibo.it (B. Biavati).
573-5214/$ – see front matter ©  2011 Royal Netherlands Society for Agricultural Scienc
oi:10.1016/j.njas.2011.04.001 All rights reserved.
Previous research has shown that in a healthy animal a well bal-
anced microbiota helps in efﬁcient digestion and maximum uptake
of nutrients, increasing the body’s resistance to infections and thus
protecting the host against certain enteropathic diseases [5,6].
The effects of the microbiota and its metabolic activities require
special consideration when viewed in the context of pig produc-
tion where animal growth and animal production are the primary
objectives [7].  The control of pathogens is of primary importance
in livestock production, because of the economically damaging
problems linked with infections caused by pathogens in newborn
animals [8].
The commensal bacterial populations inhabiting the intestinal
tract of pigs have been recognized to play important roles in organ,
tissue and immune system development, as well as in providing a
variety of nutritional compounds [9].  If the microbiota is compro-
mised, an overgrowth of pathogenic bacteria may  occur, giving rise
es. Published by Elsevier B.V. All rights reserved.
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o gastrointestinal disorders impairing growth performances of the
nimals, lowering their resistance to endogenous and exogenous
pportunistic pathogens, weakening digestive capability causing
oorer nutrient uptake and even death [5]. As for animal health
nd animal production, an important objective is to be able to
anipulate the gut microbiota, and qualitative modiﬁcations to the
iet seem to be a way that could lead to a desiderable microbiota
omposition.
Including micro-ingredients such as probiotics (live beneﬁcial
acteria) and prebiotics (substrates designed to stimulate groups
f desirable bacteria), alone or in combination (synbiotics) in the
eaner diet of pigs may  help to obtain a gradual change in intesti-
al microbiota after weaning and may  stimulate beneﬁcial bacteria
ike biﬁdobacteria and lactobacilli in the large intestine [10–13].
his nutritional approach may  lead to a repopulation of normal gut
icrobiota so that the animal’s appetite and ability to efﬁciently
tilize feedstuff returns and the problem of post-weaning stress or
rowth may  be solved [14].
Probiotics are a heterogeneous group of microbes currently used
s biotherapeutic agents that are known to have beneﬁcial effects
n the digestive ecosystem and to confer resistance to infections.
he commonly used probiotics are strains of intestinal origin and
elong to the lactic acid producing bacteria (LAB – e.g., Lacto-
acillus spp., Biﬁdobacterium spp. and Streptococcus spp.) [6,15,16].
he ability of LAB cells to survive in gastric and bile conditions
nd to adhere to the intestinal epithelium may  confer a compet-
tive advantage and is important for bacterial maintenance in the
astrointestinal tract [17]. However, the beneﬁcial effects of pro-
iotic micro-organisms appear when they arrive in the gut alive,
iologically active and in high enough numbers to be able to with-
tand the host’s natural barriers against ingested bacteria [18,19].
herefore, the intake of a probiotic in combination with a suitable
rebiotic (synbiotic) can result in synergistic effects, improving
he survival of probiotic bacteria in the host’s gastrointestinal
ract (GIT), enabling the incorporation of the probiotics into the
utochthonous bacterial community and stimulating growth activ-
ties of both exogenous (probiotics) and endogenous bacteria. Also
ther approaches have been proposed that increase resistance of
acteria sensitive to adverse conditions. Viability loss of probiotics
n acidic bile conditions of GIT has encouraged researchers to ﬁnd
ew methods of viability improvement [20]. Microencapsulation
nd encapsulation methods that previously have been reported as
echnologies that can provide protection to these sensitive cultures
uring transit through the host’s GIT, have been applied to increase
urvival and delivery of bacterial cultures [21].
Furthermore, it has recently been shown that compounds such
s nitrates, naturally present in food like vegetables and fruits
22], become powerful antimicrobial agents in acid conditions pre-
ailing in the stomach. Nitrates therefore increase the resistance
o pathogens, whereas acids alone would only have a bacterio-
tatic effect [23]. The mechanism by which dietary nitrates exploit
actericidal effects is still unclear. It seems to be related to the
roduction of nitrite in acidic conditions to reactive nitrogen com-
ounds including nitrous acid, peroxynitrite, nitrogen dioxide and
ostly nitric oxide [24]. Approximately 25% of dietary nitrate is re-
irculated by a process known as enterosalivary circulation. Nitrites
re formed from nitrates in the oral cavity by nitrate reductase
xpressed by micro-organisms in the mouth and then re-secreted
nto the upper intestinal tract [22,23,25].  Nitrates can have antimi-
robial effects not only on intestinal pathogens like Salmonella,
ersinia and Escherichia coli strains, but also on Helicobacter pylori
26], a bacterium that is held responsible for ulcers in the mucous
f the stomach. Also ulcers in the stomach represent a problem
rom the commercial point of view of livestock production, due
o a reduction in the feed conversion ratio and in animal growth
27]. Furthermore, the recirculation of nitrates by the organism intoal of Life Sciences 58 (2011) 149– 156
enterosalivary circulation would also suggest a beneﬁcial function
of nitrates for the animals [22].
This study aimed to develop a new suitable and orally adminis-
tered natural treatment that would promote the gut’s microbiota
balance and improve growth performances of weaning piglets as an
alternative to antibiotic growth promoters. To this end a number
of in vivo experiments were carried out to evaluate the effects of
dietary supplementation with probiotics, prebiotics, synbiotics and
nitrate on gut’s microecology, and health and growth performances
of piglets during weaning.
2. Materials and methods
2.1. Study design
The experimental design included two  phases: (1) an initial
screening of probiotics, prebiotics and dietary nitrate to develop
the treatments and the doses to be used, and subsequently (2) a
ﬁeld study evaluating the resulting formula.
2.1.1. Screening of probiotics and prebiotics
The probiotic ability was  assessed of 12 different Biﬁdobacterium
strains selected from the species B. breve, B. suis, B. animalis subsp.
lactis and B. choerinum.  The probiotic effect of 3 strains of each Biﬁ-
dobacterium species was investigated on 60 pigs, using a dose of
1010 colony-forming units (cfu) per pig (Table 1). Each strain was
fed to a group of 5 pigs; the control group comprised 4 pigs.
Three additives from a total population of endogenous lac-
tic acid bacteria were assessed for their prebiotic effects. The
non-digestible oligosaccharides (NDOs) were (1) Actilight® a
fructo-oligosaccharide (FOS) from sugar beet (sbFOS), (2) Raftiline®
a FOS from chicory inulin (ciFOS), and (3) Vivnal tGos®, a galacto-
oligosaccharide (GOS) from milk whey. The prebiotics were tested
at two doses: 1% and 4% (w/w)  of the diet. Each dose was fed to a
group of 10 piglets; the control group comprised 4 pigs.
2.1.2. Probiotic + prebiotic testing
The most active probiotics resulting from the above screen-
ing tests were strain Ra 18 of Biﬁdobacterium animalis subsp. lactis
and strain Su 891 of B. choerinum.  The interactions with the most
active prebiotic (sbFOS) were independently evaluated for their
dosage-related effects in two  factorial experiments, each with 2
replications. Each experiment, included 4 doses of the candidate
probiotic Biﬁdobacterium strain: 0, 107 cfu, 109 cfu, and 1011 cfu per
pig per day with or without sbFOS at 4% (w/w) of the diet, result-
ing in 16 treatment combinations per test. Each experimental unit
consisted of 4 pigs.
Microbiological analyses were done on samples of ceacum con-
tents.
2.1.3. Nitrate experiment
The impact was  assessed of two  doses of nitrate, supplied as
potassium salt, on normal stomach and upper intestine micro-
biota and on ulceration levels in the stomach of piglets challenged
with Salmonella enterica serovar typhimurium. The piglets were
challenged with 1.5 ml  orally supplied broth containing 109 cfu
Salmonella enterica serovar typhimurium. Control piglets received
a placebo consisting of broth only.
A total of 6 × 16 piglets were randomly assigned to one of
the following six treatments: (1) basal diet; (2) basal diet + 15 mg
potassium nitrate (KNO3) per kg feed; (3) basal diet + 150 mg
KNO3 per kg feed; (4) basal diet + salmonella; (5) basal diet + 15 mg
KNO3 per kg feed + salmonella; (6) basal diet + 150 mg  KNO3 per
kg feed + salmonella. A good weaning diet was formulated also
for these tests. Half the number of pigs were sacriﬁced on day
7 (+2 after being challenged), and the other half on day 25 (+20
M. Modesto et al. / NJAS - Wageningen Journal of Life Sciences 58 (2011) 149– 156 151
Table 1
Effects of diet, challenge and days since challenge on average values of bacteria in the stomach and in the jejunum contents of piglets fed diets with a high nitrate (Ni) content.
Dieta SEM Challenge salmonella SEM Days since challenge SEM
C Ni15 Ni150 No Yes 2 20
Stomach
E. colib 2.90 3.21 3.44 0.34 3.04 3.32 0.28 2.96 3.40 0.29
LAB 5.99  6.09 6.19 0.34 6.19 5.99 0.28 6.97 5.20 0.28c
Yeasts 5.29 5.31 5.45 0.24 5.40 5.30 0.20 5.57 5.13 0.20
Clostridia 5.61 5.54 5.96 0.31 5.84 5.56 0.25 6.39 5.02 0.25c
Biﬁdobacterium spp. 6.41 6.18 6.38 0.12 6.38 6.26 0.10 6.53 6.11 0.09
Jejunum
E.  colib 5.82 5.90 6.01 0.32 6.32 5.50 0.26d 5.96 5.86 0.26
LAB 6.55  7.17 6.51 0.21f 6.93 6.56 0.17 7.14 6.35 0.17c
Yeasts 5.79 5.87 5.82 0.22 5.82 5.83 0.18 5.78 5.88 0.18
Clostridia 7.05 7.13 7.17 0.20 7.31 6.92 0.17e 7.16 7.07 0.16
Biﬁdobacterium spp. 6.82 7.07 6.46 0.19 6.65 6.91 0.16 6.86 6.70 0.16
Note: There were no statistically signiﬁcant interactions (p < 0.05) between factors.
a C = control – 0 mg  KNO3 per kg feed; Ni15 – 15 mg  KNO3 per kg feed; Ni150 – 150 mg KNO3 per kg feed.
b Only 32 piglets had detectable values: 10 for C, 12 for Ni15; 10 for Ni150; 20 for unchallenged, 12 for challenged piglets.
c Statistically signiﬁcant effect of duration of challenge (p < 0.01).
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e Effect of challenge statistically different at p = 0.10.
f Contrast Ni15 vs Ni150 statistically signiﬁcant at p < 0.05.
fter being challenged). Immediately after slaughter, the stom-
ch was removed for counting the ulcers and for measuring pH
f its contents. The stomach content, the gastric and caudal part of
he jejunum contents were removed aseptically and prepared for
icrobial analysis.
Microbiological analyses were done on samples of stomach and
audal part of jejunum contents.
.2. Animals
In the ﬁrst phase of the study the piglets (Landrace × Large
hite) were weaned at 21 days and were assigned to the different
reatments (probiotics, prebiotics, etc.), using the criteria of having
imilar initial live weights and being equally representative for the
itter of origin.
Throughout the ﬁrst three tests, except for the ﬁrst 2 days of the
robiotic screening and the probiotic + prebiotic testing, the pigs
ere penned individually, fed ad libitum,  and housed in two iden-
ical rooms with controlled temperature. The daily feed intake was
egistered, and any residual feed was removed and weighed. Every
ay, 1 ml  of a skimmed milk solution with or without the preﬁxed
ose of each Biﬁdobacterium strain was added to the feed trough.
or the ﬁrst 2 days of the probiotic and probiotic + prebiotic tests,
he piglets of the dietary groups were housed together in one or
wo pens and orally administered the probiotic solution.
The experiment with dietary nitrate was performed in four con-
ecutive batches. The pigs were housed two by two  in pens with
latted ﬂoors. From the start until day 5, the pigs were offered the
xperimental diets in their pen. Thereafter the pigs were challenged
nd individually penned in the same type of pens. The challenge
rganism was orally administered in the form of 1.5 ml  broth con-
aining 109 cfu of Salmonella enterica serovar typhimurium. Control
igs received a placebo consisting of broth only. To calculate the
aily live weight gain, the piglets were weighed at the start and
t the end of the experiment, which lasted 2 weeks on average. In
ine with the protocol approved by the Ethical Committee of the
niversity of Bologna, the piglets were anaesthetized with sodium
hiopenthal (10 mg  per kg body weight) then sacriﬁced (euthana-
ia) by an intracardiac injection with Tanax® (0.5 ml  per kg body
eight).
In the probiotic, prebiotic, and probiotic + prebiotic tests, the
iglets were sacriﬁced over a 3-day period, and were taken from the
reatment in such a way that the day of sacriﬁce was distributedequally over the 3 days, enabling to calculate an average day of
sacriﬁce and thus minimizing differences between treatments.
In the nitrate experiments, half the number of pigs in each exper-
imental batch were sacriﬁced on day 7 (+2 after challenge), and half
on day 25 (+20 after challenge). All animals were sacriﬁced at the
same time after their last meal. Feed was available until 2 h and
water until 1 h prior to sacriﬁce.
2.3. Series synbiotic formula
The suitability, tolerance and positive effects of the new
synbiotic combination formula that resulted from the previous
experiments were tested on an organic farm under ﬁeld conditions.
The synbiotic formula was composed of:
1. The putative probiotic strain Ra 18 belonging to the species B.
animalis subsp. lactis (microencapsulated with a protocol devel-
oped by Probiotical srl) at a daily dose of 390 × 109 cfu per
animal;
2. The NDO extracted from sugar beet, Actilight®, at a daily dose of
4% of the diet;
3. Potassium nitrate at a daily dose of 150 mg  per kg feed.
Two  independent feeding experiments including a total of 58
40-days-old piglets (Large White × Suffolk) were started at the ﬁrst
day of weaning. The time of adaptation to the experimental condi-
tions was  3 days, after which the animals were fed the diet normally
used on the farm supplemented or not with the experimental for-
mula. The feed was  supplied once a day, but the animals were not
fed individually. Each experiment (Trials 1 and 2) comprised a total
of 20 piglets distributed over two  groups: a group fed the synbi-
otic formula and a control group fed the basal diet. Each group
was divided in two replicates based on similar levels of mean body
weight. The replicates (ﬁve piglets each) were housed in separate
pens. The formula was supplied only for 2 weeks, but in all experi-
ments the animals were observed over a period of 1 month. Faecal
samples for microbiological analysis were collected at three dif-
ferent moments: (1) T0, when the experiment started, (2) T1, 15
days later, and (3) T2, in the wash-out period, after two weeks from
ending the period of observation.Body weights were determined every 2 weeks starting at day 1
until the last day of the experiment to calculate body weight gain.
Feed intake was  recorded every two weeks by offering a weighed
quantity of feed and weighing their residues. The feed conver-
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ion ratio was calculated by dividing feed intake by body weight
ain.
Microbiological analyses were done on samples of faeces.
.4. Microbial analyses
After collection, each sample (caecum content, stomach or
ejunum content, faeces,) was weighed (1 g) accurately into a
0 ml  plastic tube and suspended homogenously in 9 ml  glyc-
rol broth to avoid qualitative and quantitative changes in the
icrobiota. The samples were then stored at −120 ◦C until anal-
sis. Additional serial 10-fold dilutions of the samples were made
n phosphate-buffered saline (PBS, Oxoid) (pH 7.2) for microbial
ounting. One millilitre of the appropriate dilutions was  plated in
riplicate onto different solid selective media employed for the
uantiﬁcation of the different bacterial species. The lactic acid
acteria (LAB), Biﬁdobacterium spp., clostridia and yeasts were
ounted using the plate count method, employing solid selective
edia.
The E. coli contents were determined with Chromocult Col-
formen Agar (Merck), after incubation in aerobiosis, at 37 ◦C
or 24 h. E. coli typically appears as blue/purple colonies
hereas coliforms appear as red/rose colonies. Testing for indole
roduction gave further conﬁrmation of the micro-organism
dentity.
LAB were quantiﬁed by plating on De Man  Rogosa Sharpe (MRS)
gar (Merck) after incubation in anaerobiosis, at 37 ◦C for 72 h. No
urther tests were conducted to identify speciﬁc micro-organisms,
nd the total microbial counts were referred to as LAB.
Yeasts (quantiﬁed only in the nitrate experiment) were cultured
n malt extract-chloramphenicol (MC) agar (38 ◦C, aerobic growth
or 2 days). The MC  agar contained (per litre) yeast extract (3 g,
erck), malt extract (3 g, Merck), peptone from meat peptic digest
5 g, Merck) d (+) glucose (10 g, Merck), and agar (15 g, Merck).
fter autoclaving, 10 ml  of 0.5% chloramphenicol in 96% ethanol
as added. Clostridia (quantiﬁed only in the nitrate experiment)
ere enumerated as colonies appearing on reinforced clostridium
gar (RCM, Merck) (37 ◦C, anaerobic growth for 2 days).
Biﬁdobacteria were selectively enumerated using modiﬁed
rypticase–phytone–yeast extract (mTPY) agar [28,29] to which
upirocin (100 mg  per litre), glacial acetic acid (1 ml  per litre),
olistin (25 mg  per litre) and nystatin, (50,000 U per litre) were
dded. The antibiotics used were purchased from Applichem GmbH
Darmstadt, Germany), except for nystatin, which was supplied
y Sigma. The plates were incubated in anaerobiosis, at 37 ◦C for
2 h. Colonies grown on mTPY agar were randomly checked for
orphology, and Gram stained.
.5. Genomic DNA extraction from biological specimens
In each trial, genomic DNA was isolated from 200 mg  of each
iological specimen (faeces, caecum, stomach and caudal part of
ejunum content) using the Qiamp DNA stool mini kit (Qiagen West
ussex, UK). The recommended lysis temperature was increased to
5 ◦C in order to improve bacterial cell rupture. The DNA was  stored
t −20 ◦C until analysis.
.6. Direct semi-quantitative Genus-PCR
A culture-independent PCR protocol was used only for conﬁrm-
ng the enumeration of Biﬁdobacterium spp. as described above
30]. Brieﬂy, after extraction from the caecum content, 10 l of
he eluted genomic DNA were serially diluted 10-fold in sterile
ouble distilled H2O. For all samples 2 l of each dilution was
mpliﬁed as described above using the primer set gBiﬁd [31]. The
iﬁdobacterium spp. titre in each caecal sample was determined byal of Life Sciences 58 (2011) 149– 156
considering the sensitivity of this procedure. The sensitivity cor-
responds to the number of Biﬁdobacterium spp. cells present in
the highest DNA dilution of each sample able to give a positive
ampliﬁcation signal.
2.7. Bacteria quantiﬁcation by real-time PCR (qPCR)
In the ﬁnal phase of the study, i.e., the synbiotic test, total
biﬁdobacteria and lactobacilli were quantiﬁed using the following
group-speciﬁc primers: RecA-F 5′-CGTYTCBCAGCCGGAYAAC-
3′ and RecA-R: 5′-CCARVGCRCCGGTCATC-3′ [32] for total
Biﬁdobacterium spp., F-Lac 5′-GCAGCAGTAGGGAATCTTCCA-
3′ and R-Lac 5′-GCATTYCACCGCTACACATG-3′ [33] for total
Lactobacillus spp. To quantify bacterial cells of B. animalis
subsp. lactis and E. coli at species level, the species-speciﬁc
primers used were: B. lactis-F: 5′-CCCTTTCCACGGGTCCC-
3′, B. lactis-R: 5′-AAGGGAAACCGTGTCTCCAC-3′ [34] and
E. coli-F: 5′-GTTAATACCTTTGCTCATTGA-3′, E. coli-R: 5′-
ACCAGGGTATCTAATCCTGTT-3′ [34]. For species-speciﬁc
quantiﬁcation of B. animalis subsp. lactis and E. coli,
Europium-probes were used too: B. lactis: 5′(HEX)-
AAATTGACGGGGGCCCGCACAAGC-(DABCYL)-3′ ([34] and E. coli:
5′(FAM)-CGTGCCAGCAGCCGCGGTA-(DABCYL)-3′ [34]. The
oligonucleotides and probes (MWG  Biotech AG, Ebersberg,
Germany) were adapted from published speciﬁc primers or probes
using the Primer Express Software (Applied Biosystems, Foster
City, CA, USA). Primers were also checked for their speciﬁcity using
the database similarity search programme nucleotide-nucleotide
BLAST [35].
Standard curves were constructed using the PCR product of the
16 S rDNA gene from E. coli (ATCC 26645) for E. coli assay; from L.
acidophilus (DSM 9126), L. casei (DSM 20011), L. lactis subsp. lactis
(DSM 20175), and L. plantarum (DSM 1055) for Lactobacillus spp.
assays and from B. animalis subsp. lactis (DSM 10140), for B. lac-
tis assay. A standard curve for Biﬁdobacterium spp. was constructed
using the PCR product of the RecA gene from B. pseudolongum subsp.
globosum (DSM 20092), B. longum (DSM 20090), B. animalis subsp.
lactis (DSM 10140), and B. biﬁdum (DSM 20082) for Biﬁdobacterium
spp. assay. The PCR product was puriﬁed with the commercial kit
NucleoSpin Extract II (Macherey-Nagel GmbH & Co. KG. Duren,
Germany) and the concentration measured at 260 nm (Biopho-
tometer, Eppendorf). Products obtained were also sequenced (BMR,
Padova, Italy) and number of copies calculated. Serial dilutions of
the products were performed in a range from 109 to 1012 copies
of the gene for calibration and construction of the proper stan-
dard curve. The functions describing the relationship between
Ct (threshold cycle) and x (log copy number) for the different
assays were: Ct = −3.807x + 45.812; r2 = 0.998 for total Biﬁdobac-
terium spp., Ct = −3.821x + 34.846; r2 = 0.993 for Lactobacillus spp.,
Ct = −3.74x + 49.338; r2 = 0.996 for E. coli, and Ct = −3.644x  + 51.025;
r2 = 0.995 for B. animalis subsp. lactis.
Real-time PCR was  performed with the Step One Real-Time PCR
System (Applied Biosystems, Foster City, CA, USA) using optical
grade 48-well plates. The reaction was performed on a total volume
of 25 l using the TaqMan or the SYBR Green chemistry (Applied
Biosystems). Each reaction included 2.5 l 10× FAST SYBR Green
Master Mix  or 10× TaqMan Gene Expression Master Mix  (Applied
Biosystems), 0.25 l of each primer (200 or 400 nmol) and 2.5 l of
ultra pure DNA samples (1 ng) and when necessary 0.25 l of the
speciﬁed probes (100 or 250 nmol). Generally, the reaction condi-
tions for ampliﬁcation of DNA were 95 ◦C for 30 s, 40 cycles of 95 ◦C
for 3 s, and 62 ◦C for 20 s. Few modiﬁcations were set for the differ-
ent assays. To determine the speciﬁcity of ampliﬁcation, analysis
of product melting curve was performed after the last cycle of each
ampliﬁcation.
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.8. Statistical analyses
All the data were processed using SAS software (SAS version 9)
ith the procedure GLM. Data from the ﬁrst phase (probiotics, pre-
iotics, probiotics + prebiotics testing) were analysed using analysis
f variance with the GLM procedure of SAS with a factor design that
ncluded: probiotic screening, diet (n = 6), litter and day of sacriﬁce;
rebiotics screening, prebiotic (n = 3), level of supplementation (1%
r 4%), their interaction and litter; probiotics + prebiotics screening,
robiotic (yes or not), level of probiotic supplementation (0; 107;
09, 1011), their interaction, replicate and litter within replicate.
The data from the nitrate experiment were analysed using anal-
sis of variance for the following three factorial models: (1) data
n vivo before challenge: diet and block (batch); (2) data post chal-
enge: model A + challenge (yes/no) and the interaction; (3) data
btained at different days of sacriﬁce: model B + day of sacriﬁce (2 or
0 days after starting the challenge) and the interaction. Orthogonal
re-planned comparisons were tested for the effect of diet: nitrate
s no nitrate addition; between different levels of nitrate addition.
he results relating to 7 pigs of the ﬁrst batch were excluded from
he statistical analysis because of the very low feed intake before
he challenge (feed intake in the total period lower than 1% of the
nitial body weight).
In the series synbiotic formula, statistical analyses on qPCR were
arried out using ANCOVA models. Differences in microbial counts
nd body weight between starting time and end of treatment, and
etween starting time and end of wash out were used as dependent
ariables. Treatment and sex were used as ﬁxed factors, whereas
nitial body weight and initial microbial counts for each bacterial
roup were used as covariates. For the analysis, microbial counts
ere used as log and for B. animalis subsp. lactis starting value
as excluded from the model as it was negative for all analysed
ubjects. The effects of different variables included in the models
ere evaluated using the F-test. For the treatments used in the
xperiments, adjusted media (least square media) were provided.
ifferences between these values were calculated and used to com-
are groups. Differences were regarded statistically signiﬁcant at
 ≤ 0.05.
. Results and discussion
The hindgut of the pig harbours a dense and metabolically
ctive microbiota comprised primarily of bacteria that have a pro-
ound inﬂuence on nutritional, immunological and physiological
rocesses in the host. Recently, more attention has been paid to
tudies of the intestinal bacterial community, notably because of
he urgent need to replace antibiotics as growth promoters in ani-
al  production [36].
Synbiotics are recognized means of modulating gut microbiota
omposition and activities. The term synbiotic refers indirectly to
 synergy, and that is what some authors have suggested that it
hould exclusively refer to: products in which the prebiotic com-
ound selectively favours the probiotic [37].
Here we describe the development of a synbiotic formula and
he study of its effect on the faecal microbiota, on growth perfor-
ance and health status of organic recently weaned piglets.
Given that the performance of probiotic strains can vary, assess-
ng in vivo their efﬁcacy could be the most appropriate approach to
haracterize the individual strains. Laboratory testing can provide
seful information for the selection of putative effective probiotic
trains, but the performance in the gut and the effect on the intesti-
al microﬂora can only be accurately determined in vivo. Recent
ata also suggest that it is the condition of the individual host
hat inﬂuences the outcome of the probiotic effect and different
esearches highlight how the gut environment tends to modify, and
hus affects the viability of ingested bacteria [38].al of Life Sciences 58 (2011) 149– 156 153
The results related to the ﬁrst phase of this study were discussed
in detail in a previous paper [30]. The study aimed at identifying
putative probiotic and prebiotic candidates, and 12 biﬁdobacteria
strains of different ecological origin and three NDOs were screened.
For identifying the best probiotic and prebiotic candidate we eval-
uated the ability of the strains and of the NDOs to modify the piglet
gut microecology.
As viable and biologically active micro-organisms are required
at the target site in the host, it is essential that probiotic strains are
able to withstand the host’s barriers against exogenous bacteria [1].
Therefore in vivo challenges are indispensable to show the
capacity of probiotics to survive after the GI transit. The most active
potential probiotic strains identiﬁed in the probiotic series, belong
to the species of B. animalis subp. lactis, (strain Ra 18) and B. choer-
inum (strain Su 891). They grow in the gut, increasing the numbers
of viable biﬁdobacteria but show different effects on health of
treated piglets.
Evaluating the inﬂuence of different prebiotic intake, it was
observed that supplementation with different FOS increased the
frequency of ﬁnding pigs that were positive for culturable biﬁ-
dobacteria in the caecum content, and the effect increased with
the dose. However, the average biﬁdobacteria counts tended to
increase only with the SbFOS supplementation, regardless of the
supplementation dose. During these two  feeding trials all pigs were
healthy: there were no signs of diarrhoea, weight loss or loss of
appetite.
Many publications that show the beneﬁcial therapeutic effect
of probiotics point to the dose–response effect. For a given strain,
variations in colonization and persistence rates can be the result of
intervention time, differences in administered dose, and the detec-
tion methods used [5,39–43].
Thus the dose–response effects of supplementation with more
than two doses of previously identiﬁed probiotic bacteria, Ra 18
and Su 891, were studied. As was previously found, the general
picture of the different synbiotic treatments with B. animalis subsp.
lactis Ra 18 and with B. choerinum Su 891, tested in these two trials
reveals that the sbFOS supplement had no effect on growth per-
formance, gut pH, or small intestine morphology of the weaned
piglets. The SbFOS only showed a tendency towards increased biﬁ-
dobacteria (p = 0.09) in the caecum only when coupled in synbiosis
with strain Ra 18. The daily live weight gain (DLWG) of the piglets
tended to improve linearly (p = 0.07) with increasing doses of B. ani-
malis subsp. lactis strain Ra 18. High doses of B. animalis subsp. lactis
had also a growth-promoting effect that was  not seen with B. cho-
erinum supplementation, though strains belonging to this species
have been suggested to be particularly well adapted to the gut of
preweaning piglets [44].
Therefore the data show that the two strains of biﬁdobacteria
(R18 and Su 891), which have similar ability in improving the count
of hindgut biﬁdobacteria, did not inﬂuence piglet growth perfor-
mance in the same way  [30].
The aim of the nitrate series was  to evaluate the host response
to the treatments with increasing doses of dietary nitrates (0 –
control; 15 mg  KNO3 per kg – Ni15; 150 mg KNO3 per kg – Ni150),
and their efﬁcacy in controlling salmonella infections in newly
weaned piglets. Indeed, recently there has been a growing interest
in the role of nitrates and nitrites in protecting mammals from
oral and gastrointestinal diseases and different studies suggest
that both nitrate and nitrite play important roles in the prevention
of infectious diseases in the gastrointestinal tract [45]. The human
enterosalivary recirculation is an intriguing phenomenon since
mammals express no enzyme capable of nitrate utilization [46].
Different in vitro studies have shown that both nitrite and low
pH contributed to the killing of pathogens such as E. coli. How-
ever, not only enterobacteria but also LAB and biﬁdobacteria are
sensitive to acidiﬁed nitrite. Sensitivity to acidiﬁed nitrite varies
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ith different species of lactobacilli, and even within the same
pecies [47].
Piglets require time to adapt to a diet rich in nitrates, but in
eneral, health was good in most of the pigs. Nitrate addition did
ot affect daily feed intake and growth, before and after challenge
48] in treated animals.
There were few signs of diarrhoea, which conﬁrms that in swine
he infection of Salmonella typhimurium is often asymptomatic.
owever, 2 salmonella control pigs, 1 salmonella Ni15 pig, and 1
ontrol Ni 150 pig died. At sacriﬁce no difference between diets was
een for pH values in the stomach and for the weight of the full and
mpty stomach. This indicates that nitrate did not affect the gastric
ecretory capacity and that, presumably, the gastric inﬂammatory
tatus did not vary.
With a dietary nitrate addition equal to the maximum dose
llowed by the EU for feedstuffs, the appearance of the gastric
ucosa is nearly always indicative of a healthy condition for pigs
f this age and the values noted were lower than those observed in
igs at the slaughterhouse [27]. The dietary addition of nitrate and
hallenge with salmonella did not affect the degree of ulceration.
The diet did not affect the content of culturable LAB, clostridia
nd yeasts in both segments, nor did it affect E. coli contents in
he jejunum. No effect of the challenge was observed on any of the
icrobial parameters. The time since challenge had an important
ffect on the counts of LAB: it decreased with age in the stomach
p < 0.001) and in the jejunum (p < 0.05). Also clostridia in the stom-
ch were reduced. With respect to the E. coli content in the stomach,
nly 35–40% of the subjects of each diet had a bacteria concentra-
ion sufﬁcient to be recoverable through culturing and the values
n the positive samples were very low (3.12 log cfu on average;
ata not presented in Table 1). In the older pigs, a trend of decreas-
ng biﬁdobacterial counts in the stomach (p = 0.07) was  noticed. The
upplementation of the diet with nitrates did not affect the bacterial
opulation density in both segments. On average, supplementation
f the diet with nitrates did not affect biﬁdobacteria concentrations
n the two digestive tracts. However, the number of biﬁdobacteria
n the jejunum tended to decrease with increasing nitrate sup-
lementation. In the jejunum contents of challenged piglets the
oncentration of E. coli was signiﬁcantly (p < 0.05) reduced and the
lostridia levels tended to decrease. This might have been due to
 niche exclusion mechanism and/or to a competition for active
ites. All challenged pigs and some unchallenged pigs were posi-
ive for salmonella presence in the lymph nodes and in the jejunum
ontents. The results indicate that a moderate addition of nitrates
oes not negatively affect growth performance, and also that the
ransfer of nitrite in the saliva was not sufﬁcient to improve the
ealth of weaning pigs stimulated with Salmonella typhimurium.
owever, in the tissue samples we only investigated the presence
f salmonella, whereas it may  have been more interesting to deter-
ine the population level of the pathogen. Indeed, more than 103
almonella bacteria are required to overcome the immune system
nd cause acute salmonella infection in the host [49]. It also has to
e underlined that we used pathogen challenge doses higher than
hose normally infecting the pigs.
The nitrite formation in the saliva was also measured (data pub-
ished in a different paper [48]). The production of saliva per unit
ime (measured before the challenge only) was not affected by
he diet. Nitrate in blood and in saliva was not affected by nitrate
upplementation. Nitrite in saliva increased with nitrate supple-
entation, but only at the ﬁrst sampling (+36%, Ni15, and +258%,
i150, p < 0.05) [48].
The level of salivary nitrite is dependent on the nitrate reduc-ase activity in the oral cavity. Yet, it may  also be markedly
ffected by the enterosalivary circulation including salivary ﬂow
ate, redox potential in the mouth and stomach, pH values in the
tomach, absorption of nitrate in the small intestine, and activeal of Life Sciences 58 (2011) 149– 156
transportation from blood to the salivary gland [47]. Studies with
rats, pigs and humans have also shown that the tongue of new-
borns are virtually free from nitrite-producing bacteria, which
results in the absence of oral nitrite and stomach nitric oxide (NO)
production. It was also hypothesized that this contributes to the
poor resistance of neonatal animals to gastroenteritis. Animals are
thought to acquire nitrite-producing bacteria both from other ani-
mals and/or the feeding environment. However, if pigs were fed
with sterile food and if the contact of newborn pigs was restricted
to the mother, nitrite population bacteria developed more slowly
and remained lower than in pigs kept under conventional intensive
rearing conditions. Furthermore, pigs raised in minimum-infection
units and under laboratory conditions might acquire a lower den-
sity of nitrite producing bacterial species than those raised under
conventional rearing conditions or in the wild [25].
At the end of the ﬁrst phase of this study a new synbiotic treat-
ment was  identiﬁed, containing the putative probiotic strain Ra 18,
belonging to the species B. animalis subsp. lactis (microencapsu-
lated with a protocol developed by Probiotical srl) at a daily dose per
animal of 390 ×109 cfu, and with NDO extracted from sugar beet,
Actilight®, at a daily dose of 4% of the diet, nitrate (as potassium
salt) at a daily dose of 150 mg  per kg feed. In the ﬁnal phase of this
study an organic farm was selected where management practices
were applied that included late weaning; an all-in farming system;
appropriate environmental conditions with regular cleaning and
disinfection of equipment and barns; hygienic conduct of employ-
ees; good air quality; appropriate pen design and space allocation
within the pen; the use of pathogen-free organic feeds, and clean
water supply. In this organic herd the piglets were usually weaned
at the age of 40 days. They were allowed in a larger housing area
without outdoor access to avoid infestation with parasites.
In this study the piglets were separated in pens with 5 animals
each, where they remained until the age of 70 days. After that the
animals were moved to the fattening unit where they were kept
until slaughter.
The weaning pens were large enough to ensure animal move-
ment, and the presence of a rest area as well as enrichment
materials like small chains (enrichment materials are playthings
for avoiding stress signs such as tail biting in penned piglets).
Two trials were designed to evaluate tolerability and suitabil-
ity in use of the new synbiotic formula. Each trial used 20 piglets
assigned to two  groups: synbiotic and non-synbiotic (control). The
tolerability and the efﬁcacy of this formula were measured by an
overall assessment of symptoms after 2 weeks of treatment: pres-
ence and/or frequency of post weaning diarrhoea, effects on growth
performance and feed efﬁciency, and changes in faecal microbiota.
The results showed a good tolerability of the new formula
together with a signiﬁcant effect on piglets’ growth performance.
Two weeks after intake the body weight of treated piglets had
increased at T1 and T2 with an average of 5.62 kg and 8.68 kg,
respectively, in the ﬁrst trial and 3.27 kg and 7.96 kg, respectively,
in the second (Tables 2 and 4). Differences between the two  groups
(synbiotic vs control) were statistically signiﬁcant (p = 0.03 at T1;
p = 0.01 at T2). Good feed efﬁciency was  also observed at the end of
the wash-out period in both trials.
Furthermore, synbiotic intake also led to signiﬁcant changes in
faecal microbiota composition of treated piglets (Tables 3 and 5).
Biﬁdobacteria and all other bacterial groups showed the same
trend: a signiﬁcant increase during the treatment and a slight
decrease at the end of the wash-out period. After 2 weeks of feed-
ing, all treated piglets showed higher numbers of beneﬁcial bacteria
like biﬁdobacteria and lactobacilli and lower numbers of potential
pathogenic bacteria like E. coli in their faeces compared with the
baseline values.
The results of many studies reported in literature [50–53]
point to a synergistc effect of probiotic and prebiotic
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Table 2
First trial. Growth performance of the groups of piglets at different growth stages.
Growth stage Control Synbiotic
Group 1 Group 1B Group 2A Group 2B
Average body weight (kg) ± SD
T0 12.1 ± 1.57 10.6 ± 0.56 12.2 ± 0.22 10.7 ± 0.83
T1 17.2 ± 2.15 15.6 ± 1.80 19.2 ± 1.20 16.1 ± 0.83
T2 25.5 ± 1.84 23.5 ± 2.11 29.7 ± 2.15 24.1 ± 0.70
Average daily weight gain (kg) ± SD
T1 0.34 ± 0.07 0.33 ± 0.15 0.47 ± 0.07 0.36 ± 0.05
T2 0.59 ± 0.03 0.56 ± 0.07 0.75 ± 0.08 0.57 ± 0.06
Average body weight (kg)
T0 −T1 5.06 4.98 7.05 5.44
T1 −T2 8.30 7.84 10.51 8.02
Feed conversion ratio (kg kg–1)
T0 − T1 1.87 1.73 1.75 1.75
T1 − T2 1.82 1.89 1.86 1.80
Table 3
First trial. Quantitative real-time PCR analysis of microbial groups in piglets faecal
samples (log10 gene copies numbers per g wet  weight ± SD).
Growth stage Control Synbiotic
E. coli
T0 6.22 ± 0.53 6.27 ± 0.53
T1 10.74 ± 0.52 8.39 ± 0.36
T2 10.20 ± 0.49 9.16 ± 0.69
Lactobacilli
T0 11.03 ± 0.80 10.98 ± 0.37
T1 10.70 ± 0.58 12.83 ± 0.52
T2 10.60 ± 0.54 11.42 ± 0.52
Biﬁdobacterium spp.
T0 10.52 ± 0.15 10.44 ± 0.19
T1 10.88 ± 0.18 13.63 ± 0.26
T2 9.72 ± 0.16 12.29 ± 0.19
Biﬁdobacterium animalis subsp. lactis
T0 0 0
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Table 5
Second trial. Quantitative real-time PCR analysis of microbial groups in piglets faecal
samples (log10 gene copies numbers per g wet weight ± SD).
Growth stage Control Synbiotic
E. coli
T0 7.09 ± 0.54 7.42 ± 0.50
T1 10.43 ± 0.34 8.46 ± 0.58
T2 10.03 ± 0.72 8.95 ± 0.59
Lactobacilli
T0 10.49 ± 0.74 10.40 ± 0.80
T1 10.16 ± 0.46 12.90 ± 0.40
T2 9.83 ± 0.39 11.14 ± 0.47
Biﬁdobacterium spp.
T0 10.47 ± 0.36 10.59 ± 0.27
T1 10.16 ± 0.29 13.64 ± 0.43
T2 9.22 ± 0.31 10.54 ± 0.18
Biﬁdobacterium animalis subsp. lactis
T0 0 0T1 0 14.09 ± 0.29
T2 0 11.24 ± 0.21
ombinations on faecal microbiota of experimental animals.
his effect was demonstrated by increased total anaerobes, aer-
bes, lactobacilli and biﬁdobacteria counts as well as by lower
lostridia, Enterobacteriaceae and E. coli counts. The combination
f probiotic and non-digestible carbohydrates may  be a way  of
tabilization and/or improvement of the probiotic effect.
The ability of Ra 18 to pass down, survive and persist in the
iglets’ GIT was also investigated by analysing the recovery of Ra
8 from faecal samples following oral intake and wash-out phase.
s expected, prior administered Ra 18 B. animalis subsp. lactis was
ot detected in the faeces of treated and untreated piglets, being a
pecies normally found in the microbiota of rabbits. However, 15
able 4
econd trial. Growth performance in the groups of piglets at different growth stages.
Growth stage Control Synbiotic
Group 1A Group 1B Group 2A Group 2B
Average body weight (kg) ± SD
T0 13.2 ± 1.20 11.3 ± 0.95 13.1 ± 0.69 11.5 ± 0.79
T1 16.6 ± 1.27 14.2 ± 1.57 16.5 ± 1.51 14.9 ± 1.45
T2 24.7 ± 1.92 22.0 ± 2.84 24.3 ± 2.20 23.0 ± 2.95
Average daily weight gain (kg) ± SD
T1 0.23 ± 0.07 0.19 ± 0.11 0.22 ± 0.13 0.22 ± 0.10
T2 0.58 ± 0.05 0.56 ± 0.10 0.56 ± 0.14 0.58 ± 0.11
Average body weight (kg)
T0 − T1 3.42 2.86 3.33 3.36
T1 − T2 8.11 7.08 7.83 8.10
Feed conversion ratio (kg kg−1)
T0 − T1 2.26 2.18 2.26 2.14
T1 − T2 1.76 1.69 1.75 1.65T1 0 14.20 ± 0.58
T2 0 12.41 ± 0.83
days after administration, the probiotic strain appeared in the fae-
ces of all treated piglets, reaching a high mean level of gene copy
numbers per gram faeces. At the end of the wash-out period, at T2,
the strain was still detectable in the faeces of all treated piglets
(Tables 3 and 5). These data are in accordance with the results
of earlier intervention trials showing that probiotic strains usu-
ally disappear within some weeks after their intake is discontinued
[54–56].
The qPCR analysis conﬁrmed that after ingestion, the putative
probiotic strain Ra 18 was  able to survive the conditions of the
piglets’ GIT and persist in the colonic ecosystem in high numbers
until 2 weeks after cessation of intake. Detection of the strain in all
follow-up samples suggests prolonged colonization in the intes-
tine of the treated piglets. Furthermore, microencapsulation of the
probiotic strain and the addition of prebiotic SbFOS have been con-
ﬁrmed to satisfactorily increase the survival of the micro-organism
during its transit in the gastrointestinal tract of the piglets. That
the microencapsulation technique is a valid tool to signiﬁcantly
improve gastroresistance of strains and to enhance their probi-
otic activity has been conﬁrmed by earlier research [57]. To the
best of our knowledge there are no publications of studies where
both probiotic biﬁdobacteria and prebiotic FOS have been studied
in synbiotic trials with weaning piglets.
The results from this study also demonstrate that the inclu-
sion of our synbiotic formula into the weaning diet affected piglets’
growth rate and feed efﬁciency. In all experiments we  also observed
differences in faecal microbiota composition between treated and
untreated piglets (Tables 3 and 5) that resulted from dietary sup-
plementation with this new formula. Our formula led to a beneﬁcial
intestinal microbiota, dominated by health-promoting bacteria
(biﬁdobacteria and lactobacilli) and to a reduction of pathogenic
bacteria like E. coli. These results are very promising since studies
on faecal samples may  underestimate the colonization of colonic
mucosa by probiotic strains.
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